You are here
TUMOREND, LLC
Company Information
Information
UEI: W12HNN776J45
# of Employees: 4
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Immunoassay for diagnosis of invasive fungal disease
Amount: $149,043.00DESCRIPTION: We have preliminary data for a small molecule glyco-decoy that specifically side-tracks the biosynthesis of the ligand for E-selection, and is a candidate for a novel anti-inflammatory. T ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
Structure-Activity Relationship of CM101 Tumor antiangiogenic agent with its lect
Amount: $150,000.00DESCRIPTION (provided by applicant): CM101 is a polysaccharide tumor angiogenesis-targeting, complement activating, immune stimulating biological produced fermentatively from Group B Streptococcus. CM ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health